Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) - Cash Flow Conversion Efficiency

Latest as of September 2024: 0.126x

Based on the latest financial reports, Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) has a cash flow conversion efficiency ratio of 0.126x as of September 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (TL33.37 Million ≈ $747.36K USD) by net assets (TL263.88 Million ≈ $5.91 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Oncosem Onkolojik Sistemler Sanayi ve Ti market capitalisation for the company's overall valuation and market capitalisation.

Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. - Cash Flow Conversion Efficiency Trend (2020–2023)

This chart illustrates how Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. ranked by their cash flow conversion efficiency. Explore cash flow quality index of Oncosem Onkolojik Sistemler Sanayi ve Ti to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Naturalendo Tech Co Ltd KQ:168330	-0.039x
Timberwell Bhd KLSE:7854	0.007x
The LEADCORP Inc KQ:012700	-0.043x
Pacgold Ltd AU:PGO	-0.032x
Wisekey International Holding AG NASDAQ:WKEY	-0.037x
Shenzhen SEG Co Ltd SHE:200058	0.109x
TOVIS Co.Ltd KQ:051360	0.035x
Nordwest Handel AG F:NWX	N/A

Annual Cash Flow Conversion Efficiency for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (2020–2023)

The table below shows the annual cash flow conversion efficiency of Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. from 2020 to 2023. View current stock price of Oncosem Onkolojik Sistemler Sanayi ve Ti for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2023-12-31	TL231.70 Million ≈ $5.19 Million	TL-38.10 Million ≈ $-853.43K	-0.164x	-169.94%
2022-12-31	TL224.08 Million ≈ $5.02 Million	TL52.69 Million ≈ $1.18 Million	0.235x	-64.14%
2021-12-31	TL78.80 Million ≈ $1.76 Million	TL51.68 Million ≈ $1.16 Million	0.656x	+156.87%
2020-12-31	TL76.02 Million ≈ $1.70 Million	TL19.41 Million ≈ $434.68K	0.255x	--

About Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.

IS:ONCSM Turkey Medical Devices

Market Cap

$50.05 Million

TL2.23 Billion TRY

Market Cap Rank

#21986 Global

#324 in Turkey

Share Price

TL93.70

Change (1 day)

-9.99%

52-Week Range

TL93.70 - TL380.00

All Time High

TL380.00